Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$9.64 – $9.82
100% from low
Exchange
OTC Link
OS
NIHON KOHDEN ORD
No one on the platform currently holds NHNKF.
No tracked institution reports a position in NHNKF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $17.0000 | |
| 2026-09-30 | $16.0000 | |
| 2026-03-31 | $16.0000 | 2026-06-26 |
| 2025-09-30 | $16.0000 | 2025-12-01 |
| 2025-03-31 | $16.0000 | 2025-06-27 |
| 2024-09-30 | $15.0000 | 2024-11-27 |
| 2024-03-28 | $31.0000 | 2024-06-27 |
| 2023-09-29 | $30.0000 | 2023-11-29 |
| Execution date | Ratio |
|---|---|
| 2024-06-27 | 2-for-1 |
No one on the platform has traded NHNKF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $236.4B | +0.6% | $96.20 | $92.72–$106.17 | 0.1× | 1 |
| 2028 | $242.1B | +2.4% | $104.69 | $100.90–$115.54 | 0.1× | 1 |
| 2029 | $251.3B | +3.8% | $113.63 | $109.51–$125.40 | 0.1× | 1 |
| 2030 | $256.7B | +2.2% | $121.16 | $116.78–$133.72 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-06 | $0.01 | $-0.03 | -352.2% |
| 2026-05-14 | $0.21 | $0.31 | +47.0% |
| 2026-02-05 | $0.08 | $0.07 | -10.9% |
| 2025-11-10 | $0.16 | $0.18 | +15.5% |
| 2025-08-07 | $0.02 | $0.01 | -65.9% |
| 2025-05-13 | $0.29 | $0.24 | -18.1% |
| 2025-02-05 | $0.14 | $0.29 | +111.3% |
| 2024-11-07 | $0.04 |
| $-0.01 |
| -128.9% |
| $1.2B |
| — |
| LUNGPulmonx Corporation | $2.42 | +12.04% | $102M | — |
| NHNKYNihon Kohden Corporation | $9.26 | +0.37% | $3.0B | — |
Source: Financial Modeling Prep · peers by sector/industry